Ani Pharmaceuticals Inc. (ANIP)
NASDAQ · Healthcare
Ani Pharmaceuticals Inc. Operating Income 2009–2025
Ani Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2012 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Ani Pharmaceuticals Inc. operating income for the quarter ending March 31, 2026 was 38.9 M, a 48.46% increase year-over-year.
- Ani Pharmaceuticals Inc. operating income for the twelve months ending March 31, 2026 was 115.2 M, a 402.90% increase year-over-year.
- Ani Pharmaceuticals Inc. annual operating income for 2025 was 111.1 M, a 18922.77% increase from 2024.
- Ani Pharmaceuticals Inc. annual operating income for 2024 was 584000, a 98.76% decrease from 2023.
- Ani Pharmaceuticals Inc. annual operating income for 2023 was 47.0 M, a 233.13% decrease from 2022.
- Ani Pharmaceuticals Inc. annual operating income for 2022 was -35.3 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Ani Pharmaceuticals Inc. Operating Income — FAQ
Ani Pharmaceuticals Inc. (ANIP) operating income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Ani Pharmaceuticals Inc.'s operating income?
Ani Pharmaceuticals Inc. (ANIP) reported operating income of $111M for fiscal 2025.
Where can I see ANIP's operating income history?
The chart and table above show Ani Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.